Lipella Pharmaceuticals’ innovative liposomal drug delivery platform receives US patent: Pittsburgh Wednesday, October 16, 2024, 17:00 Hrs [IST] Lipella Pharmaceuticals Inc., a ...

Patent application covers key technology innovations for delivering therapeutic agentsProprietary technology enables precise ...

Patent application covers key technology innovations for delivering therapeutic agentsProprietary technology enables precise delivery to improve safety and efficacy in oncology, cancer survivorship an ...

With the recent patent allowance and ongoing clinical trials, Lipella Pharmaceuticals is poised for significant advancements in its therapeutic offerings. The company’s focus on conditions with high ...

It can appear on various parts of the body, including the mouth, where it’s known as oral lichen planus. While oral lichen planus itself is not cancerous, having it can increase the risk of ...

Dolphins are known for what appear to be big, contagious smiles. But do they actually, well, smile? The answer, according to a new study of dolphin play, is a resounding “maybe.” Dolphins use ...

Lichen planus is an itchy skin rash that may affect the quality and duration of sleep, which could cause fatigue. The skin condition is also linked with anxiety, depression, and a lower quality of ...

they need to rule out other conditions that can cause burning in the mouth. These include: Thrush (oral yeast infection) Lichen planus Geographic tongue In order to do this, your dentist will look in ...

Head and neck squamous cell carcinoma (HNSCC), which develop in the mouth, nose, and throat ... rate of a particularly dangerous strain of oral human papillomavirus (HPV) – all of which are ...

1 Department of Stomatology Center, The First People’s Hospital of Foshan, Foshan, China 2 Department of Stomatology, Foshan Hospital of Traditional Chinese Medicine, Foshan, China Background: Oral ...

PITTSBURGH - Lipella Pharmaceuticals Inc. (NASDAQ:LIPO), a clinical-stage biotechnology company, has shared promising early results from its Phase 2a clinical trial of LP-310, an investigational ...